Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Otitis Media - Overview
Otitis Media - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Otitis Media - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Otitis Media - Companies Involved in Therapeutics Development
Lee’s Pharmaceutical Holdings Ltd
Madam Therapeutics BV
Merck & Co Inc
MerLion Pharmaceuticals Pte Ltd
Novus Therapeutics Inc
Yuhan Corp
Otitis Media - Drug Profiles
(cholesteryl palmitate + colfosceril palmitate) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(dexamethasone + piperacillin + tazobactam) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
fifloxacin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pazufloxacin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PCL-1440 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pneumococcal (13-valent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pneumococcal (23-valent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Recombint Peptide to Inhibit D for Otitis Media and Haemophilus Influenzae Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Otitis Media - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
solithromycin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Otitis Media - Dormant Projects
Otitis Media - Product Development Milestones
Featured News & Press Releases
Jan 30, 2019: Novus Therapeutics Advances OP0201 Development Program Across Several Clinical Trials
Jan 10, 2019: Novus doses first patient in Phase I trial of OP0201
Dec 04, 2018: Novus Therapeutics announces formation of Scientific Advisory Board
Nov 28, 2018: Novus Therapeutics doses first subject in Phase I trial of OP0201
Jun 19, 2018: Novus Therapeutics Receives FDA Guidance at Type C Meeting for OP-02 in the Treatment and Prevention of Otitis Media
Jun 02, 2017: Eight Presentations at ASM Microbe Include Late Breaker From Cempra’s Phase 3 Fusidic Acid Study and Solithromycin Data on Gonorrhea and Otitis Media
Oct 29, 2012: Study Suggests New Way to Prevent Recurrent Ear Infections
Apr 18, 2012: MerLion Initiates Phase III Clinical Program To Evaluate Fifloxacin For Treatment Of Acute Otitis Media
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Otitis Media, H1 2019
Number of Products under Development by Companies, H1 2019
Number of Products by Targets, H1 2019
Number of Products by Stage and Targets, H1 2019
Number of Products by Mechanism of Actions, H1 2019
Number of Products by Stage and Mechanism of Actions, H1 2019
Number of Products by Routes of Administration, H1 2019
Number of Products by Stage and Routes of Administration, H1 2019
Number of Products by Molecule Types, H1 2019
Number of Products by Stage and Molecule Types, H1 2019


List of Tables


Number of Products under Development for Otitis Media, H1 2019
Number of Products under Development by Companies, H1 2019
Number of Products under Development by Universities/Institutes, H1 2019
Products under Development by Companies, H1 2019
Products under Development by Universities/Institutes, H1 2019
Number of Products by Stage and Target, H1 2019
Number of Products by Stage and Mechanism of Action, H1 2019
Number of Products by Stage and Route of Administration, H1 2019
Number of Products by Stage and Molecule Type, H1 2019
Otitis Media - Pipeline by Lee’s Pharmaceutical Holdings Ltd, H1 2019
Otitis Media - Pipeline by Madam Therapeutics BV, H1 2019
Otitis Media - Pipeline by Merck & Co Inc, H1 2019
Otitis Media - Pipeline by MerLion Pharmaceuticals Pte Ltd, H1 2019
Otitis Media - Pipeline by Novus Therapeutics Inc, H1 2019
Otitis Media - Pipeline by Yuhan Corp, H1 2019
Otitis Media - Dormant Projects, H1 2019